Glucose-Lowering With Exogenous Insulin Monotherapy in Type 2 Diabetes: Dose-Response Association With All-Cause Mortality, Cardiovascular Events, and Incident Cancer
Value in Health - United Kingdom
doi 10.1016/j.jval.2014.03.1403
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2014
Authors
Publisher
Elsevier BV